Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenium | 14 | 2022 | 144 | 7.100 |
Why?
|
| Lyases | 7 | 2021 | 51 | 3.840 |
Why?
|
| Selenoproteins | 12 | 2022 | 151 | 3.410 |
Why?
|
| Obesity | 7 | 2021 | 965 | 1.820 |
Why?
|
| Selenoprotein P | 3 | 2019 | 50 | 1.400 |
Why?
|
| Glutathione Peroxidase | 6 | 2021 | 109 | 1.290 |
Why?
|
| Liver | 4 | 2021 | 447 | 1.110 |
Why?
|
| Thermogenesis | 2 | 2022 | 20 | 1.010 |
Why?
|
| Energy Metabolism | 7 | 2022 | 160 | 0.980 |
Why?
|
| Tilapia | 2 | 2021 | 7 | 0.960 |
Why?
|
| Nutritional Status | 3 | 2021 | 114 | 0.890 |
Why?
|
| Sex Characteristics | 3 | 2021 | 213 | 0.890 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2021 | 8 | 0.830 |
Why?
|
| Thyroxine | 1 | 2021 | 17 | 0.830 |
Why?
|
| Triiodothyronine | 1 | 2021 | 30 | 0.820 |
Why?
|
| Iodide Peroxidase | 1 | 2021 | 32 | 0.820 |
Why?
|
| Cardiovascular System | 1 | 2021 | 30 | 0.810 |
Why?
|
| Simvastatin | 1 | 2021 | 28 | 0.800 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 8 | 0.790 |
Why?
|
| Dyslipidemias | 1 | 2021 | 42 | 0.780 |
Why?
|
| Organoselenium Compounds | 1 | 2020 | 9 | 0.770 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 77 | 0.760 |
Why?
|
| Azoles | 1 | 2020 | 13 | 0.760 |
Why?
|
| Mice, Knockout | 8 | 2021 | 897 | 0.760 |
Why?
|
| Metabolome | 1 | 2019 | 47 | 0.710 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 257 | 0.690 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 63 | 0.690 |
Why?
|
| Animals | 15 | 2021 | 14307 | 0.680 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 70 | 0.680 |
Why?
|
| Amino Acids | 1 | 2019 | 139 | 0.680 |
Why?
|
| Dietary Supplements | 2 | 2021 | 196 | 0.670 |
Why?
|
| Food, Fortified | 1 | 2016 | 17 | 0.550 |
Why?
|
| Blood Glucose | 2 | 2018 | 333 | 0.520 |
Why?
|
| Phosphotransferases | 1 | 2014 | 35 | 0.490 |
Why?
|
| Adipose Tissue, Brown | 3 | 2022 | 39 | 0.460 |
Why?
|
| Mice | 7 | 2021 | 5668 | 0.450 |
Why?
|
| Neoplasms | 1 | 2022 | 1033 | 0.450 |
Why?
|
| Male | 11 | 2021 | 18870 | 0.410 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 2 | 2021 | 14 | 0.400 |
Why?
|
| Diet | 1 | 2016 | 747 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1530 | 0.350 |
Why?
|
| Oxidative Stress | 3 | 2021 | 874 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 592 | 0.330 |
Why?
|
| Leptin | 3 | 2021 | 115 | 0.310 |
Why?
|
| Female | 8 | 2021 | 19873 | 0.310 |
Why?
|
| Gene Deletion | 2 | 2021 | 156 | 0.300 |
Why?
|
| Humans | 10 | 2022 | 34853 | 0.290 |
Why?
|
| Selenocysteine | 1 | 2022 | 52 | 0.220 |
Why?
|
| Adipocytes | 1 | 2022 | 54 | 0.220 |
Why?
|
| Gills | 1 | 2021 | 10 | 0.210 |
Why?
|
| Salinity | 1 | 2021 | 13 | 0.210 |
Why?
|
| Fish Proteins | 1 | 2021 | 11 | 0.210 |
Why?
|
| Acclimatization | 1 | 2021 | 20 | 0.210 |
Why?
|
| Brazil | 1 | 2021 | 66 | 0.200 |
Why?
|
| Body Weight | 2 | 2021 | 404 | 0.200 |
Why?
|
| Mice, Obese | 1 | 2021 | 37 | 0.200 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 65 | 0.200 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 92 | 0.200 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 13 | 0.200 |
Why?
|
| Creatinine | 1 | 2021 | 101 | 0.200 |
Why?
|
| Selenious Acid | 1 | 2020 | 3 | 0.190 |
Why?
|
| Isoindoles | 1 | 2020 | 17 | 0.190 |
Why?
|
| Virulence | 1 | 2020 | 221 | 0.180 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 283 | 0.180 |
Why?
|
| Myocardium | 1 | 2021 | 224 | 0.180 |
Why?
|
| Metabolomics | 1 | 2019 | 76 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 109 | 0.170 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 115 | 0.170 |
Why?
|
| Virus Replication | 1 | 2020 | 261 | 0.160 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 42 | 0.150 |
Why?
|
| Hypothalamus | 2 | 2018 | 122 | 0.150 |
Why?
|
| Cells, Cultured | 1 | 2021 | 1442 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1300 | 0.140 |
Why?
|
| Trace Elements | 1 | 2016 | 25 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 32 | 0.140 |
Why?
|
| Palmitic Acid | 1 | 2015 | 24 | 0.130 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 51 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 628 | 0.130 |
Why?
|
| Molecular Biology | 1 | 2015 | 44 | 0.130 |
Why?
|
| Neurons | 1 | 2021 | 1130 | 0.120 |
Why?
|
| Research | 1 | 2015 | 159 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 192 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Hyperinsulinism | 1 | 2012 | 17 | 0.110 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 36 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 49 | 0.110 |
Why?
|
| Putamen | 1 | 2012 | 15 | 0.110 |
Why?
|
| Universities | 1 | 2015 | 363 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2012 | 56 | 0.100 |
Why?
|
| Substantia Nigra | 1 | 2012 | 41 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 338 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 245 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2012 | 167 | 0.090 |
Why?
|
| Cognition | 1 | 2013 | 373 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2128 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 66 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 78 | 0.050 |
Why?
|
| Orchiectomy | 1 | 2018 | 33 | 0.040 |
Why?
|
| Hawaii | 2 | 2015 | 1878 | 0.040 |
Why?
|
| Weight Gain | 1 | 2018 | 128 | 0.040 |
Why?
|
| Adiposity | 1 | 2018 | 145 | 0.040 |
Why?
|
| Insulin | 1 | 2018 | 224 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 641 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 650 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1007 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1681 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2021 | 1802 | 0.030 |
Why?
|
| Locomotion | 1 | 2013 | 91 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 20 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2012 | 72 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 48 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2013 | 304 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 528 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2333 | 0.020 |
Why?
|